HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospital.

AbstractBACKGROUND:
The COVID-19 pandemic may induce post-traumatic stress disorder (PTSD) symptoms among patients with cancer, who also face adaptations to their treatment. The authors assessed the occurrence of PTSD symptoms, investigated pandemic-induced adjustments in medical oncology practice in patients with cancer, and explored risk factors for PTSD and the association between PTSD symptoms, insomnia, and quality of life (QoL).
METHODS:
This prospective French study was conducted in patients with solid/hematologic tumors who were receiving medical treatment in the day care departments of 2 cancer centers during the lockdown. Adjustments to medical oncology practice were collected from medical records. PTSD (measured using the Impact of Event Scale-Revised), insomnia (measured using the Insomnia Severity Index), QoL (measured using the Functional Assessment of Cancer Therapy-General instrument), and cognitive complaints (measured using the Functional Assessment of Cancer Therapy-Cognitive Function instrument) were collected through validated questionnaires.
RESULTS:
Clinical data and questionnaires were available for 734 and 576 patients, respectively. The median patient age was 64 years, and 69% of patients were women. Twenty-one percent of patients had PTSD. Twenty-seven percent (95% CI, 23%-30%) had an adjustment in their medical oncology program, including adjournments (29%), treatment interruptions (16%), modified treatment plans (27%), or adapted monitoring (27%). Women and patients experiencing an adjustment in oncology practice had a higher odds of PTSD (odds ratio= 2.10 [95% CI, 1.07-4.14] and 1.65 [95% CI, 1.03-2.63]; P < .05). PTSD symptoms were correlated with worse scores for QoL, cognition, and insomnia.
CONCLUSIONS:
Twenty-one percent of patients with cancer experienced PTSD symptoms associated with poor QoL during the first COVID-19-induced lockdown. Medical oncology practice was adjusted in approximately one-quarter of patients and was associated with the occurrence of PTSD symptoms. Psychosocial support should be offered in cancer centers to promote emotional resilience and avoid PTSD symptoms in patients.
AuthorsFlorence Joly, Olivier Rigal, Lydia Guittet, Sophie Lefèvre-Arbogast, Jean-Michel Grellard, Giulia Binarelli, Marie Lange, Chantal Rieux, Marie Fernette, Laure Tron, François Gernier, Romain Travers, Adeline Morel, Doriane Richard, Bénédicte Griffon, Alexandra Leconte, Etienne Bastien, Florian Quilan, Louis-Ferdinand Pépin, Fabrice Jardin, Marianne Leheurteur, Bénédicte Clarisse, Justine Lequesne, Audrey Faveyrial
JournalCancer (Cancer) Vol. 127 Issue 24 Pg. 4636-4645 (12 15 2021) ISSN: 1097-0142 [Electronic] United States
PMID34398970 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 American Cancer Society.
Topics
  • Adult
  • COVID-19 (psychology)
  • Communicable Disease Control
  • Day Care, Medical
  • Female
  • France
  • Hospitals
  • Humans
  • Male
  • Medical Oncology
  • Middle Aged
  • Neoplasms (epidemiology, psychology)
  • Pandemics
  • Prospective Studies
  • Quality of Life
  • Sleep Initiation and Maintenance Disorders (epidemiology, etiology)
  • Stress Disorders, Post-Traumatic (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: